Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation: An algorithm to predict on-clopidogrel platelet reactivity

Go Miura, Noritaka Ariyoshi, Yasunori Sato, Hiroki Yamaguchi, Yo Iwata, Yoshihide Fujimoto, Yoshio Kobayashi, Itsuko Ishii

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Antiplatelet effects of clopidogrel appear to be affected by various factors including genetic polymorphism. So far, there has been little information about the response of clopidogrel in Asians, whose prevalence of a CYP2C19 loss-of-function (LOF) allele is high. Methods and Results: We investigated background and clinical factors affecting on-clopidogrel platelet reactivity in Japanese patients undergoing coronary stent implantation (n = 114). In univariate analysis, antiplatelet effects of clopidogrel in a steady state were associated with not only CYP2C19 genotypes but also several factors including dyslipidemia. In addition, we developed an algorithm that can estimate P2Y12 Reaction Units (PRU) in a steady state by multiple regression analysis and evaluated the adequacy of the algorithm by the Akaike Information Criterion. Conclusions: We revealed several factors influencing on-clopidogrel platelet reactivity in Japanese patients. We also succeeded in developing an algorithm that estimates PRU in a steady state, although it is uncertain whether the algorithm can be applied to other populations.

Original languageEnglish
Pages (from-to)877-883
Number of pages7
JournalThrombosis Research
Volume134
Issue number4
DOIs
Publication statusPublished - Oct 1 2014
Externally publishedYes

Fingerprint

clopidogrel
Stents
Blood Platelets
Genetic Polymorphisms
Dyslipidemias
Alleles
Genotype
Regression Analysis

Keywords

  • AIC
  • Algorithm
  • Clopidgrel
  • CYP2C19
  • Pharmacogenetics
  • VerifyNow

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation : An algorithm to predict on-clopidogrel platelet reactivity. / Miura, Go; Ariyoshi, Noritaka; Sato, Yasunori; Yamaguchi, Hiroki; Iwata, Yo; Fujimoto, Yoshihide; Kobayashi, Yoshio; Ishii, Itsuko.

In: Thrombosis Research, Vol. 134, No. 4, 01.10.2014, p. 877-883.

Research output: Contribution to journalArticle

Miura, Go ; Ariyoshi, Noritaka ; Sato, Yasunori ; Yamaguchi, Hiroki ; Iwata, Yo ; Fujimoto, Yoshihide ; Kobayashi, Yoshio ; Ishii, Itsuko. / Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation : An algorithm to predict on-clopidogrel platelet reactivity. In: Thrombosis Research. 2014 ; Vol. 134, No. 4. pp. 877-883.
@article{56feb656c5f0447986339e5183ad69d8,
title = "Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation: An algorithm to predict on-clopidogrel platelet reactivity",
abstract = "Introduction: Antiplatelet effects of clopidogrel appear to be affected by various factors including genetic polymorphism. So far, there has been little information about the response of clopidogrel in Asians, whose prevalence of a CYP2C19 loss-of-function (LOF) allele is high. Methods and Results: We investigated background and clinical factors affecting on-clopidogrel platelet reactivity in Japanese patients undergoing coronary stent implantation (n = 114). In univariate analysis, antiplatelet effects of clopidogrel in a steady state were associated with not only CYP2C19 genotypes but also several factors including dyslipidemia. In addition, we developed an algorithm that can estimate P2Y12 Reaction Units (PRU) in a steady state by multiple regression analysis and evaluated the adequacy of the algorithm by the Akaike Information Criterion. Conclusions: We revealed several factors influencing on-clopidogrel platelet reactivity in Japanese patients. We also succeeded in developing an algorithm that estimates PRU in a steady state, although it is uncertain whether the algorithm can be applied to other populations.",
keywords = "AIC, Algorithm, Clopidgrel, CYP2C19, Pharmacogenetics, VerifyNow",
author = "Go Miura and Noritaka Ariyoshi and Yasunori Sato and Hiroki Yamaguchi and Yo Iwata and Yoshihide Fujimoto and Yoshio Kobayashi and Itsuko Ishii",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.thromres.2014.07.018",
language = "English",
volume = "134",
pages = "877--883",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation

T2 - An algorithm to predict on-clopidogrel platelet reactivity

AU - Miura, Go

AU - Ariyoshi, Noritaka

AU - Sato, Yasunori

AU - Yamaguchi, Hiroki

AU - Iwata, Yo

AU - Fujimoto, Yoshihide

AU - Kobayashi, Yoshio

AU - Ishii, Itsuko

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Introduction: Antiplatelet effects of clopidogrel appear to be affected by various factors including genetic polymorphism. So far, there has been little information about the response of clopidogrel in Asians, whose prevalence of a CYP2C19 loss-of-function (LOF) allele is high. Methods and Results: We investigated background and clinical factors affecting on-clopidogrel platelet reactivity in Japanese patients undergoing coronary stent implantation (n = 114). In univariate analysis, antiplatelet effects of clopidogrel in a steady state were associated with not only CYP2C19 genotypes but also several factors including dyslipidemia. In addition, we developed an algorithm that can estimate P2Y12 Reaction Units (PRU) in a steady state by multiple regression analysis and evaluated the adequacy of the algorithm by the Akaike Information Criterion. Conclusions: We revealed several factors influencing on-clopidogrel platelet reactivity in Japanese patients. We also succeeded in developing an algorithm that estimates PRU in a steady state, although it is uncertain whether the algorithm can be applied to other populations.

AB - Introduction: Antiplatelet effects of clopidogrel appear to be affected by various factors including genetic polymorphism. So far, there has been little information about the response of clopidogrel in Asians, whose prevalence of a CYP2C19 loss-of-function (LOF) allele is high. Methods and Results: We investigated background and clinical factors affecting on-clopidogrel platelet reactivity in Japanese patients undergoing coronary stent implantation (n = 114). In univariate analysis, antiplatelet effects of clopidogrel in a steady state were associated with not only CYP2C19 genotypes but also several factors including dyslipidemia. In addition, we developed an algorithm that can estimate P2Y12 Reaction Units (PRU) in a steady state by multiple regression analysis and evaluated the adequacy of the algorithm by the Akaike Information Criterion. Conclusions: We revealed several factors influencing on-clopidogrel platelet reactivity in Japanese patients. We also succeeded in developing an algorithm that estimates PRU in a steady state, although it is uncertain whether the algorithm can be applied to other populations.

KW - AIC

KW - Algorithm

KW - Clopidgrel

KW - CYP2C19

KW - Pharmacogenetics

KW - VerifyNow

UR - http://www.scopus.com/inward/record.url?scp=84908133806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908133806&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2014.07.018

DO - 10.1016/j.thromres.2014.07.018

M3 - Article

C2 - 25175362

AN - SCOPUS:84908133806

VL - 134

SP - 877

EP - 883

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 4

ER -